JD Health International Inc.
JDHIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.35 | 1.83 | 0.03 | -0.76 |
| FCF Yield | 8.37% | 2.88% | 3.11% | 3.70% |
| EV / EBITDA | 21.99 | 206.48 | 55.18 | -21,053.46 |
| Quality | ||||
| ROIC | 3.28% | 0.21% | 1.64% | -0.34% |
| Gross Margin | 25.20% | 22.16% | 23.64% | 21.43% |
| Cash Conversion Ratio | 2.41 | 0.99 | 1.09 | 7.25 |
| Growth | ||||
| Revenue 3-Year CAGR | 45.55% | 54.60% | 65.98% | 74.07% |
| Free Cash Flow Growth | 200.62% | -7.00% | -46.89% | 1,112.66% |
| Safety | ||||
| Net Debt / EBITDA | -11.01 | -93.46 | -7.58 | 3,176.26 |
| Interest Coverage | 0.00 | 841.40 | 128.70 | -48.72 |
| Efficiency | ||||
| Inventory Turnover | 3.54 | 3.97 | 3.81 | 3.73 |
| Cash Conversion Cycle | -29.39 | -16.08 | -19.82 | -15.28 |